Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal epithelial cell membrane and its associated glycocalyx form the primary biological barrier of the ocular surface, crucial for maintaining optical clarity and protecting the eye from environmental insults. The glycocalyx is a carbohydrate-rich layer composed mainly of membrane-associated mucins, specifically MUC1, MUC4, and MUC16, which are anchored to the microplicae of the apical epithelial cells (Gipson, 2004, Exp Eye Res). This structure creates a hydrophilic interface that allows the aqueous tear film to spread evenly, providing essential lubrication and preventing the adhesion of pathogens and debris (Mantelli & Argüeso, 2008, Curr Opin Ophthalmol). In pathological conditions such as dry eye disease or Sjögren's syndrome, the integrity of the glycocalyx is often compromised, leading to tear film instability, increased friction, and epithelial cell damage (Watanabe, 2002, Cornea). Therapeutic strategies targeting this complex involve the use of secretagogues like diquafosol or rebamipide to enhance mucin production, as well as mucomimetic polymers that reinforce the protective barrier (Govindarajan & Gipson, 2010, Exp Eye Res). Understanding the molecular composition of this layer is vital for developing effective treatments for ocular surface disorders and improving the bioavailability of topically applied ophthalmic drugs.
Restoration of mucin expression, stabilization of the tear film, and provision of a protective mucomimetic coating to the ocular surface.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal epithelial cell membrane and glycocalyx.